Stage IVB Prostate Cancer AJCC v8 Clinical Trials in Lexington, Kentucky

4 studies are recruiting for stage ivb prostate cancer ajcc v8 in Lexington, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by bl…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Kentucky/Markey Cancer Center, Lexington, Kentucky
    Locations
    581 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03866382 on ClinicalTrials.gov

  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    CommonSpirit Saint Joseph Hospital - Lexington, Lexington, Kentucky
    Locations
    341 in total
    Run by
    ECOG-ACRIN Cancer Research Group

    See if you can join NCT04423211 on ClinicalTrials.gov

  3. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastatic). Neuroendocrine differentiation refers to cells that have traits of both hormone-producing endoc…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Kentucky/Markey Cancer Center, Lexington, Kentucky
    Locations
    13 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05691465 on ClinicalTrials.gov

  4. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation the…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky
    Locations
    338 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT03678025 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.